LEADING THE WAY

to a more comfortable treatment experience

At Midatech Pharma US Inc, we are taking oncology supportive care in a new direction. Our unique portfolio of innovative products is designed to help make each patient’s treatment journey as smooth as possible.

With a 23% increase in cancer survival rates over the last 21 years,

quality of life for patients has become a major issue1,2

Oncology supportive care is “care given to support the quality of life in cancer patients. The goal is to prevent or treat as early as possible the symptoms of the disease, the side effects caused by treatment, and psychological, social, and spiritual problems caused by the disease.”

—American Cancer Society

The Midatech Direct Rx Access Program:

Prescribe with confidence

More than 14,000 patients successfully enrolled and growing...

More than $9M invested in our commitment to ensure patients have access to the treatments they need

For Patients

IMPORTANT:

Pharmacy will contact patients directly to verify insurance coverage

Patients must confirm their insurance information with pharmacy before prescription is shipped

*Terms and Conditions: Certain patients in Federal programs may not qualify. Qualified patients will pay $0 per GELCLAIR/ZUPLENZ/ORAVIG prescription. After a maximum reimbursement allowance, any remaining costs will be the responsibility of the patient. Co-pay assistance is not valid for prescriptions reimbursed, in whole or in part, under Medicaid, Medicare, including Medicare Advantage and Part D prescription drug plans, or any other federal or state program (including state pharmaceutical assistance programs) or where prohibited, taxed, or otherwise restricted. Midatech Pharma US Inc reserves the right to rescind, revoke, or amend this offer without notice. Patients understand and agree to comply with the terms and conditions of this offer as set forth here.

GELCLAIR is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland. Under license of Helsinn Healthcare SA, Switzerland.Oravig is under exclusive license from Onxeo SA, France.All other trademarks are the property of their respective owners.Marketed and distributed by Midatech Pharma US Inc., Raleigh, NC 27615 info@midatechpharmaus.com